Citation Impact
Citing Papers
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
2013 StandoutNobel
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells
2004
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
Intratracheal Administration of a Nanoparticle-Based Therapy with the Angiotensin II Type 2 Receptor Gene Attenuates Lung Cancer Growth
2012
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism
2005 StandoutNobel
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
2002
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
1999
Enhanced Diagnosis of Pneumococcal Meningitis with Use of the Binax NOW Immunochromatographic Test ofStreptococcus pneumoniaeAntigen: A Multisite Study
2009
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
The role of tumor stroma in the interaction between tumor and immune system
2005
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Necroptosis and its role in inflammation
2015 StandoutNature
Bortezomib‐induced apoptosis in mature T‐cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl‐1
2008
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Tumor immunoediting and immunosculpting pathways to cancer progression
2007
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Cell Death
2004 Standout
Novel Conjugation of Tumor‐Necrosis‐Factor‐Related Apoptosis‐Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery
2013
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Functions of natural killer cells
2008 Standout
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal
2003
Surface expression of O‐specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein
2000
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
2009 Standout
Association between a High-Expressing Interferon-γ Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC2 Patients
2002
Nuclear war: the granzyme A-bomb
2003
How regulatory T cells work
2008 Standout
Tuberous sclerosis
2008 Standout
Apoptosis
2002 Standout
Death receptor signal transducers: nodes of coordination in immune signaling networks
2009
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Functional significance of the perforin/granzyme cell death pathway
2002
EMT: 2016
2016 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Molecular signals in anti-apoptotic survival pathways
2001
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Classification of cytotoxic T-cell and natural killer cell lymphomas
2003
Microenvironmental regulation of metastasis
2008 Standout
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
The STATs of cancer — new molecular targets come of age
2004 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Caspase-independent cell death in T lymphocytes
2003
Combination immunotherapy: a road map
2017
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
TRAIL-mediated signaling in prostate, bladder and renal cancer
2011
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
2015 Nature
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
SPI-CI and SPI-6 cooperate in the protection from effector cell–mediated cytotoxicity
2004
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
1999
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
2010
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
1999
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
2001
NK Cells and Cancer
2007
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1
2001
Tumor Immunity in Perforin-Deficient Mice: A Role for CD95 (Fas/APO-1)
2000
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
2001
IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy
2018
Functional Analysis of Granzyme M and Its Role in Immunity to Infection
2005
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
IL-21 Induces the Functional Maturation of Murine NK Cells
2004
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Activation of NK cell cytotoxicity
2004
Lipopolysaccharide Endotoxins
2002 Standout
Diet-Induced Obesity Alters Dendritic Cell Function in the Presence and Absence of Tumor Growth
2012
gp130 at the nexus of inflammation, autoimmunity, and cancer
2010
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Works of Alan D. Brooks being referenced
Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex
2010
Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity
2009
Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
2014
Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand
2003
A cell-based high-throughput screen to identify synergistic TRAIL sensitizers
2008
The Restricted Expression of Granzyme M in Human Lymphocytes
2001
NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function
2006
The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP
2003
Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
1998
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
2009
IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells
2000
Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
2003
Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells
1998
Molecular cloning of the structural gene for exopolygalacturonate lyase from Erwinia chrysanthemi EC16 and characterization of the enzyme product
1990
Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin
2002
T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas
2000